FDA Grants Full Approval for Mirvetuximab Soravtansine-gynx (Elahere) for FRα positive, platinum-resistant epithelial ovarian with Robert Coleman, MD Ovarian 4 Mins Read1 The recent approval by the Food and Drug Administration (FDA) of mirvetuximab soravtansine-gynx (Elahere) marks a significant advancement in the…
Niraparib Treatment in Patients With Advanced Ovarian Cancer Ovarian 1 Min Read1 Rafael G. Amado, M.D., President, Head of Global Oncology Research and Development, leading and overseeing the company’s global oncology research…
SOLO-1 Phase 3 [2022]: Newly Diagnosed Advanced Ovarian Cancer Ovarian 10 Mins Read3 SOLO-1 Phase 3 [2022]: Newly Diagnosed Advanced Ovarian Cancer Research  Dr. Greg Rossi talks with OncologyTube about the SOLO-1…
